<DOC>
	<DOCNO>NCT01461772</DOCNO>
	<brief_summary>Concurrent chemoradiation therapy weekly cisplatin current standard treatment patient locally advanced cervical cancer . However , weekly cisplatin related renal toxicity convenient regimen . Recently , carboplatin prove good radiosensitizer less renal toxicity . Weekly carboplatin convenient regimen patient physician . Weekly carboplatin may similar efficacy weekly cisplatin may favorable toxicity profile . Therefore , investigator aim evaluate efficacy safety concurrent chemoradiation weekly carboplatin patient locally advanced cervical cancer .</brief_summary>
	<brief_title>Efficacy Safety Study Concurrent Chemoradiation Therapy Treat Locally Advanced Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Previously untreated , histologically confirm cervical cancer One follow histologic type Squamous carcinoma , adenocarcinoma , adenosquamous carcinoma Age : 2075 year GOG performance status : 02 Adequate organ function Bone marrow : WBC ≥ 3,000/mm3 , ANC ≥ 1,500/mm3 , Platelet ≥ 100X103/mm3 , Hb ≥ 10.0 g/dl Kidney : Creatinine &lt; 1.25 × UNL , Liver : AST , ALT &lt; 3 × UNL , T bilirubin &lt; 1.5 mg/ mm3 Contraception study treatment Informed consent Previous chemotherapy pelvic radiation therapy Hormone therapy within 4 week Concomitant malignancy within 5 year except cure basal cell carcinoma skin Uncontrolled medical disease Pregnant lactate woman Etc .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>